Psychdata - Dedicated to exposing the fraud of psychiatry: Doctoring the Evidence: GlaxoSmithKline Pushes Depression Drug
Tuesday, August 14, 2007
Doctoring the Evidence: GlaxoSmithKline Pushes Depression Drug
http://corpwatch.org/article.php?id=14606
Doctoring the Evidence: GlaxoSmithKline Pushes Depression Drug
by Shelley Jofre, Special to Corp Watch
July 30th, 2007
A striking young woman with a talent for painting, Sharise Gatchell was - like many teenagers - painfully self-conscious. At 14, she moved with her family from South Africa to England where at first she found it hard to make friends. By the age of 16 she was acutely embarrassed that her periods hadn't started and felt she was sweating excessively. Just the sort of thing to make adolescence even more painful than usual. Her mother, Stephanie, took her to see a consultant physician at the local hospital. Stephanie Gatchell recalls:
.............
...........................
Meanwhile, Stephanie Gatchell and her husband have moved away from the home that holds so many awful memories, to start a new life in Ireland. They can't forgive GlaxoSmithKline for concealing what it knew about paroxetine:
"I can't understand how they could possibly be so devious, and all just because of profit. I think the decision-makers in that company should be brought to justice. They have a lot to explain."
*Shelley Jofre is a reporter with BBC TV's flagship current affairs program: Panorama. To learn more about Sharise Gatchell, see http://www.gevil.netopti.net/.
GlaxoSmithKline issued a statement in response to Shelley Jofre's investigation.
Posted by Psychdata at 9:30 PM
No comments:
Post a Comment
Note: only a member of this blog may post a comment.